Modivcare Inc. announced on August 21, 2025, that it received a notification from Nasdaq regarding the commencement of proceedings to delist the company’s common stock. This decision follows Modivcare’s voluntary filing for Chapter 11 bankruptcy on August 20, 2025.
Nasdaq also cited the company's delinquency in timely filing its quarterly report on Form 10-Q for the fiscal quarter ended June 30, 2025, as a reason for non-compliance with listing rules. Trading in Modivcare’s common stock is scheduled to be suspended at the opening of business on August 28, 2025.
The company does not intend to appeal Nasdaq’s delisting decision. It is expected that Nasdaq will file a Form 25-NSE with the SEC to remove the common stock from listing and registration. Modivcare anticipates that its common stock will be quoted on the OTC Pink Market after delisting, though no assurance can be provided regarding continued trading on this market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.